He has two identities in use, we aren’t deadnaming him.I see. Still probably could use his current persona name though right?
He has two identities in use, we aren’t deadnaming him.I see. Still probably could use his current persona name though right?
I addressed this in my previous statement with the attached Janoshik reports.This sounds contradictory to me. On one hand, Cain says he didn't know whether histidine was used with retatrutide. On the other hand, Cain says Nexaph remade the batch. If Nexaph is the one making the retatrutide, then it seems Nexaph would know know what it placed into it. If Nexaph is truly unaware of what it used to make a batch, that's just as scary if not more scary than Nexaph having intentionally added the histidine in the first place. Also, if Nexaph is unaware of what fillers it uses in batches, then I don't see how Nexaph can make a statement now that it never used histidine for GLP-1 drugs.
You got banned for asking these questions? I am the only one that can ban people, and i find it unlikely these where the questions asked that got you banned.@Cain_SPC - while you’re here:
1. Does SNP/SPC finish their own peptides?
2. Does SNP/SPC own the finishing facility?
3. Does SNP/SPC synthesize any peptides?
I asked these questions on your Telegram but got banned.
How else would you run a vendor funded, 3rd party test?Your condescension knows no bounds, it’s really something.
The person organizing the test volunteered to collect names and lists of vials to keep them straight (several different peps and batches being tested). Those vials were sent directly by customers who volunteered to the lab, Peptide Test. In other words, random people volunteered to send in a vial and put them in bubble mailers and sent to PT. PT does the tests. Cain pays for the tests. Tests are available to those of us who purchased a given batch first, then released to the commuting writ large. JUST LIKE A GB. How can that be manipulated by the vendor?
It can’t be.
It sounds like people would be more comfortable with buyers paying for the test themselves, and submitting a receipt to Cain for a refund? I may be misunderstanding.How else would you run a vendor funded, 3rd party test?
There is no way that Test Point/Peptide Test is going to risk their reputation to cater the results to Nexaph's needs even if they are paying for the tests.
There a so many vendors out there that don't even provide COA's or provide old COA's (look at the COA for QSC's black Friday promo on 20mg Reta, the COA is from May) the fact that he is willing to fund 3rd party tests tells me he has a high confidence level in his product. He has also established a track record of replacing substandard product without buyers even requesting a replacement, Show me another gray kit vendor that does this.
He said that the questionable filler was not used with glp1s after all (it seems fine with non-glp1s other than potentially masking impurities, but not interacting with the peptide itself). He had thought it was used w reta and stated as much, which was the origin of the controversy, but has walked that back.I think everyone here is talking so much about the testing drama that the real scandal is going unaddressed: the formula changes he made that appeared to compromise the integrity of products he was sending customers.
You can direct message each other, find out the Telegram user name, and then definitely answer whether that got someone banned.You got banned for asking these questions? I am the only one that can ban people, and i find it unlikely these where the questions asked that got you banned.
He said that the questionable filler was not used with glp1s after all (it seems fine with non-glp1s other than potentially masking impurities, but not interacting with the peptide itself). He had thought it was used w reta and stated as much, which was the origin of the controversy, but has walked that back.
Human biases come into play when funding is involved. Even if Colgate does nothing but hand over the money, most humans have an inherent tendency to not want to bite the hands that feed. Science consistently sees results that are less likely to be reproduced by independent studies when the original findings are funded by a company with financial interest in the outcome.That's not the same thing unless Colgate also owns or can otherwise control the person/lab who is putting out the results.
Editing for clarity:
Colgate can fund all the studies they want, and as long as they're not manipulating the people doing the studies, who cares who pays for it?
Jano was seeing peptides that had bad impurities, said to baba “hey these peptides look like shit did you use a new filler?,” to which baba said yes it was the filler, apparently erroneously. So at the end of the day Jano was just seeing baba’s conventional poorly made peptides. Thats the story as I understand it.How does that align with what Janoshik said?
Jano was seeing peptides that had bad impurities, said to baba “hey these peptides look like shit did you use a new filler?,” to which baba said yes it was the filler, apparently erroneously. So at the end of the day Jano was just seeing baba’s conventional poorly made peptides. Thats the story as I understand it.
Yes that’s correct.So we're left with two options regarding what actually happened here:
1.Nexaph is distributing poor quality peptides
2. Nexaph used a filler that damaged the quality of their product
Which resulted in a poor quality peptide that he automatically replaced without users even needing to request replacement.So we're left with two options regarding what actually happened here:
1.Nexaph is distributing poor quality peptides
2. Nexaph used a filler that damaged the quality of their product
This is false, Jano never advised against giving it to customers. He said he would advise me against using it in formulations just because they wont be able to test it right as its not a common excipient they are used to testing. That is the reason why i had to send them a sample of the histidine so they can test it properly against their own tests.And to everyone acting like this whole thing is just some witch-hunt, I want to point out that the origin of it was this message from baba himself where he says Jano asked about major impurities, and that the reason was histidine:
https://glp1forum.com/threads/nexaph-first-purchase-retatrutide.1066/post-20586
Then, Jano discussed how histidine interacts with glp1s in unpredictable ways and he would advise baba not to give that to customers (which again, is precisely what baba told everyone he had done):
https://glp1forum.com/threads/nexaph-testing.1336/post-28777
There was only one conclusion to be reached based on all of that.
So kindly chill with the “oh no Cain is such a victim” simping here. None of it would have happened if he hadn’t been shipping poor quality products before testing (a sin he commits over and over and over), or if he knew what was in the vials that he sent people (since he apparently thought he had used histidine in the reta per the first link above).
OK, on re-interpreting the conversation I give you that he said he would advise you against using it because "it can, unlike traditional fillers, obscure impurities," not that you shouldn't sent it to customers. Although if this non-traditional filler (using Jano's words) is potentially obscuring impurities, should you be sending it to customers? I suppose that would be good for you, maybe not so much the customer.This is false, Jano never advised against giving it to customers. He said he would advise me against using it in formulations just because they wont be able to test it right as its not a common excipient they are used to testing. That is the reason why i had to send them a sample of the histidine so they can test it properly against their own tests.
Either way, histidine was never used with GLP's. It is used with Tesamorelin and will continue to be used with that as we have found Tesamorelin is most stable with histidine as its buffer along with mannitol and sucrose.
Which resulted in a poor quality peptide that he automatically replaced without users even needing to request replacement.
I have had good experiences with them as well, but even if we assume no malicious intent, Cain has shown a startling lack of good judgement.
Cain doesn't seem to have the instincts to understand right from wrong, high risk decisions from low ones, and for that reason he shouldn't be entrusted with anyone's health.
Its non-traditional for THEM to test for. As the Chinese vendors they are used to testing for don't use it. I will link an article for you to read about histidine and maybe can give you some insight on why pharma companies that have FDA approved products use it.OK, on re-interpreting the conversation I give you that he said he would advise you against using it because "it can, unlike traditional fillers, obscure impurities," not that you shouldn't sent it to customers. Although if this non-traditional filler (using Jano's words) is potentially obscuring impurities, should you be sending it to customers? I suppose that would be good for you, maybe not so much the customer.
This is false, Jano never advised against giving it to customers. He said he would advise me against using it in formulations just because they wont be able to test it right as its not a common excipient they are used to testing.
Either way, histidine was never used with GLP's. It is used with Tesamorelin...